MENLO PARK, Calif. , Dec. 1, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted...
Explore insider buying signals, a promising cancer detection biotech, and why the American Dream is still achievable—even in a down market.
MENLO PARK, Calif. , Nov. 18, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million
MENLO PARK, Calif. , Nov. 4, 2025 /PRNewswire/ --Â GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management...
Analyst Day 2025 Webcast to Begin at 11:00 a.m. ET on November 13 th
MENLO PARK, Calif. , Oct. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has entered...
One-Third of Participants Initially Believed to Have a False-Positive Result Were Later Diagnosed With Cancer During Follow Up
More Than Half of Cancers Detected by Galleri Were Early Stage
Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions